Duane syndrome

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Research: Duane syndrome

Duane syndrome (DS) is an eye movement disorder present at birth (congenital) characterized by a limited ability to move an eye inward towards the nose (adduction), outward towards the ear (abduction), or in both directions. In addition, when the affected eye(s) move inward towards the nose, the eyeball retracts (pulls in) and the eye opening (palpebral fissure) narrows. In some cases when the eye attempts to look inward, it moves upwards (upshoot) or downwards (downshoot).

Similar to CFEOM, Duane syndrome falls under the larger heading of strabismus (misalignment of the eyes) under the subclassification of incomitant strabimsus (misalignment of the eyes which varies with gaze directions) and subheading of extraocular muscle fibrosis syndromes (conditions associated with restriction of both active and passive movement of the eyeball). Although "muscle fibrosis" suggests that syndromes under this heading are primary disorders of muscle, evidence suggests that DS (and other Congenital Cranial Dysinnervation Disorders-CCDD's) may actually be primary disorders of nerve innervation21, 22

show_more_start

Clinical classification and description

Duane syndrome is often clinically subdivided into three types: 1-3. Different clinical types may be present within the same family suggesting that the same genetic defect may produce a range of clinical presentations4.

Duane syndrome Type 1: The ability to move the affected eye(s) outward towards the ear (abduction) is limited, but the ability to move the affected eye(s) inward towards the nose (adduction) is normal or nearly so. The eye opening (palpebral fissure) narrows and the eyeball retracts into the orbit when looking inward towards the nose (adduction). When looking outward towards the ear (abduction) the reverse occurs.

Duane syndrome Type 2: The ability to move the affected eye(s) inward towards the nose (adduction) is limited, whereas the ability to move the eye outward (abduction) is normal or only slightly limited. The eye opening (palpebral fissure) narrows and the eyeball retracts into the globe when the affected eye(s) attempt to look inward towards the nose (adduction).

Duane syndrome Type 3: The ability to move the affected eye(s) both inward towards the nose (adduction) and outward towards the ear (abduction) is limited. The eye opening (palpebral fissure) narrows and the eyeball retracts when the affected eye(s) attempt to look inward towards the nose (adduction).

Each of these three types can be further classified into three subgroups designated A, B, and C to describe the eyes when looking straight (in primary gaze)1. In subgroup A the affected eye is turned inward towards the nose (esotropia). In subgroup B the affected eye is turned outward towards the ear (exotropia), and in subgroup C the eyes are in a straight primary position.

The frequency of DS in the general population of individuals with eye movement disorders (strabismus) is approximately 1-5%1. Most individuals are diagnosed by the age of 10 years5. The most common clinical presentation is Type 1 DS (78%) followed by types 3 and 2 (15% and 7% of cases, respectively)1. Involvement of both eyes (bilateral) is less common than involvement of one eye only (unilateral); approximately 80% of cases are unilateral1,5. Of the unilateral cases, the left eye is more often affected (72%). The female to male ratio of individuals with DS is 60:40, showing a slightly higher preponderance of female patients1,3,5.

Duane syndrome is usually an isolated finding (approximately 70%), but may be associated with other malformations1,3,5,6. Major anomalies associated with DS can be grouped into four categories: skeletal, auricular (having to do with the ears), ocular (having to do with the eyes) and neural (having to do with the nervous system). DS can also be associated with other well-defined syndromes. These include Okihiro syndrome (Duane syndrome with radial ray anomalies)7, Wildervanck syndrome3, Holt-Oram syndrome8, Morning Glory syndrome6, and Goldenhar syndrome9.

Clinical evaluation

A thorough family history and ocular (eye) examination is conducted, with special attention to the presence of other ocular or systemic malformations. Measurements of vision (visual acuity), the ocular misalignment, ocular range of motion, head turn, globe (eyeball) retraction, palpebral fissure (eye opening) size, and up- and downshoots are indicated. In addition, an examination of the cervical (neck) and thoracic (chest) spine, palate (roof of mouth), vertebrae, hands, and a hearing test is recommended to rule out disorders associated with DS3,13.

Genetics

Both genetic and environmental factors are likely to play a role in the development of Duane syndrome. The majority of Duane syndrome cases are sporadic in origin with only approximately 2-5% of patients showing a familial pattern (running in families)10, and large families are rarely reported. Both dominant and recessive forms of DS have been documented. In some families with dominant DS, it has skipped a generation (shown reduced penetrance) and ranged in severity within the same family (shown variable expressivity)11,12. Most familial cases are not associated with other anomalies1.

The first gene for Duane syndrome was identified by members of our laboratory in 2002. This was not for isolated Duane syndrome but for Duane syndrome with radial ray anomalies, a disease that was found to map to Chromosome 20. SALL4 was identified as being the causative gene for the disorder24.

Genetic linkage studies of a single large family with isolated DS has established the location of a DS gene on chromosome 24, the DURS2 region. This finding was followed up with a report in 200023 of a 4-generation family with Duane syndrome in the U.K. that was linked to this locus and refined the region to an interval of 8.8-cM.

Cytogenetic results (a study of chromosomes) of individuals with Duane syndrome have, in rare cases, shown abnormalities that suggest that there may be more than one gene responsible for causing DS. Deletions of chromosomal material on chromosomes 418 and 819, and the presence of an extra marker chromosome thought to be derived from chromosome 2220 have been documented in DS individuals.

Pathology

Both neuropathologic, neuroradiologic, and neurophysiologic studies support the hypothesis that Duane syndrome results from an absence of cranial nerve VI (abducens nerve). Neuropathologic evidence comes from postmortem examinations of individuals who had DS14,15. These studies have shown an absence of cranial nerve VI and its correponding alpha motor neurons in the pons, and aberrant innervation of the lateral rectus muscle (the muscle that moves the eye outward towards the ear) by a branch of cranial nerve III. Magnetic resonance imaging (MRI) studies of an individual with DS also revealed the absence of the abducens nerve (cranial nerve VI)16. Neurophysiological evidence for neuronal involvement in DS comes from electromyographic (EMG) studies which show that the medial and lateral recti muscles are electrically active in individuals with DS. When individuals with DS attempt to move their eyes inward (adduct), however, both of these muscles contract at the same time, resulting in the eyeball retracting inward (pulling in) and the eye opening (palpebral fissure) narrowing5,10,17. These findings support the aberrant innervation of the lateral rectus muscle.

Given the evidence that DS results from an absence of the abducens nerve (cranial nerve VI) and that DS is associated with other anomalies in some cases, it is thought that DS results from a disturbance of normal embryonic development, by either a genetic or an environmental factor, at the time when the cranial nerves and ocular muscles are developing, between 3-8 weeks gestation3,10.

Standard therapies

The standard management of Duane syndrome may involve surgery. The goal of surgery is the elimination or improvement of an unacceptable head turn, the elimination or reduction of significant misalignment of the eyes, the reduction of severe retraction and the improvement of upshoots and downshoots3,10,17. Surgery does not eliminate the fundamental abnormality of innervation and no surgical technique has been completely successful in eliminating the abnormal eye movements. Simple horizontal muscle recession procedures, vertical rectus muscle transposition procedures, or combinations of the two may be successful in improving or eliminating head turns and misalignment of the eyes. The choice of procedure must be individualized.

Please contact Caroline Andrews to obtain further information on the genetic studies that we are undertaking and if you are interested in enrolling a patient or participating yourself.

show_more_end

DURS2 locus

show_more_start

The is a region of DNA on the q arm of Chromosome 2 (2q31) for which researchers have mapped a disease gene for isolated Duane syndrome1. This region was identified following undertaking a genome wide screen on the DNA of a large Mexican family (consisting of 118 members), spanning 4 generations, with fully penetrant autosomal dominant Duane syndrome. All 24 affected family members had limited abduction, with narrowing of the palpebral fissure and retraction of the globe on adduction. In addition, some family members had limited adduction and some members had amblyopia and the majority had vertical as well as horizontal movement abnomalities.

Subsequent to this study, a 4 generation English family with fully penetrant Duane syndrome was studied, that also mapped to the DURS2 region, enabling the region to be reduced to an 8.8-cM interval on chromosome 22.

In collaboration with researchers who mapped the DURS2 locus, we are currently using a positional cloning approach to identify this gene, by utilizing DNA from families enrolled in this research study.

Please contact Caroline Andrews to obtain further information on the genetic studies that we are undertaking and if you are interested in enrolling a patient or participating yourself.

References

Online Mendelian Inheritance in Man (OMIM). Victor A. McKusick, Editor, Johns Hopkins University, last edit date 12/15/99 (entry number 604356). Home page: http://www3.ncbi.nlm.nih.gov/Omim/.

  • Appukuttan, B. et al. Localization of a gene for Duane retraction syndrome to chromosome 2q31. American Journal of Human Genetics 65;1639-1646 (1999).

  • Evans JC, Frayling TM, Ellard S, Gutowski NJ. Confirmation of linkage of Duane's syndrome and refinement of the disease locus to an 8.8-cM interval on chromosome 2q31. Hum Genet. 2000 Jun;106(6):636-8.

show_more_end

DURS1 locus

show_more_start

The DURS1 locus was defined by the presence of cytogenetic abnormalities (abnormal chromosome number and/or structure) on the q arm of Chromosome 8 in individuals manifesting Duane syndrome. No Duane Syndrome family to date has been reported to map to this locus by linkage analysis.

The first reported individual1 had Duane Syndrome, branchio-oto-renal (BOR) syndrome, hydrocephalus, and trapezius muscle aplasia associated with a de novo 8q12.2-q21.2 deletion. The second individual2 had Duane Syndrome Type 1, microcephaly, mental retardation, and dysmorphic features and an insertion of 8q13-q21.2 onto 6q25 with an associated deletion of 8q13. The third patient had DS and hypoplastic external genitalia and a reciprocal translocation of t(6;8)(q26;q13)3 and Pizzuti et al in 20024 determined that the chr 8 breakpoint in this individual was between exons 1 and 2 of a carboxypeptidase gene, CPAH. Although they did not identify any mutations in this gene in 18 sporadic (isolated) Duane syndrome participants, CPAH, a gene involved in peptide processing of the brain, still remains a good candidate gene for this disorder.

More recently, Anwar et al5 described patients with trisomy 8 and Duane syndrome.

Please contact Caroline Andrews to obtain further information on the genetic studies that we are undertaking and if you are interested in enrolling a patient or participating yourself.

References

Online Mendelian Inheritance in Man (OMIM). Victor A. McKusick, Editor, Johns Hopkins University, last edit date 3/3/2005 (entry number 126800). Home page: http://www3.ncbi.nlm.nih.gov/Omim/.

  1. Vincent C, Kalatzis V, Compain S, Levilliers J, Slim R, Graia F, Pereira ML, Nivelon A, Croquette MF, Lacombe D, et al.. A proposed new contiguous gene syndrome on 8q consists of branchio-oto-renal (BOR) syndrome, Duane syndrome, a dominant form of hydrocephalus and trapeze aplasia; implications for the mapping of the BOR gene. Human Molecular Genetics 3, 1859-1866 (1994).

  2. Calabrese G, Stuppia L, Morizio E, Guanciali Franchi P, Pompetti F, Mingarelli R, Marsilio T, Rocchi M, Gallenga PE, Palka G, Dallapiccola B.. Detection of an insertion deletion of region 8q13-q21.2 in a patient with Duane syndrome: implications for mapping and cloning a Duane gene. European Journal of Human Genetics 6, 187-193 (1998).

  3. Calabrese G, Telvi L, Capodiferro F, Morizio E, Pizzuti A, Stuppia L, Bordoni R, Ion A, Fantasia D, Mingarelli R, Palka G.. Narrowing the Duane syndrome critical region at chromosome 8q13 down to 40 kb. Eur J Hum Genet 8, 319-24 (2000).

  4. Pizzuti A, Calabrese G, Bozzali M, Telvi L, Morizio E, Guida V, Gatta V, Stuppia L, Ion A, Palka G, Dallapiccola B.. A peptidase gene in chromosome 8q is disrupted by a balanced translocation in a duane syndrome patient. Invest Ophthalmol Vis Sci 43, 3609-12 (2002).

  5. Anwar, S., Bradshaw, K. & Vivian, A.J. Ophthalmic manifestations of trisomy 8 mosaic syndrome. Ophthalmic Genet 19, 81-6 (1998).

show_more_end

Request an Appointment

If this is a medical emergency, please dial 9-1-1. This form should not be used in an emergency.

Patient Information
Date of Birth:
Contact Information
Appointment Details
Send RequestIf you do not see the specialty you are looking for, please call us at: 617-355-6000.International visitors should call International Health Services at +1-617-355-5209.
Please complete all required fields

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

Thank you.

Your request has been successfully submitted

You will be contacted within 1 business day.

If you have questions or would like more information, please call:

617-355-6000 +1-617-355-6000
close
Find a Doctor
Search by Clinician's Last Name or Specialty:
Select by Location:
Search by First Letter of Clinician's Last Name: *ABCDEFGHIJKLMNOPQRSTUVWXYZ
BrowseSearch
Condition & Treatments
Search for a Condition or Treatment:
Show Items Starting With: *ABCDEFGHIJKLMNOPQRSTUVWXYZ
View allSearch
Locations
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO
Close